Xyosted 75 MG/0.5 ML auto-INJ 0.5ML
Ended Awarded
- Contract number
- SPE2DB25FY9LG
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $1,086
Award facts
- Contract value 100% obligated
- $1,086.44 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $1,086.44 to AmerisourceBergen Drug Corp for the supply of Xyosted 75 mg/0.5 ml auto-injector units. The contract, awarded on August 15, 2025, with an ultimate completion date of August 18, 2025, represents a firm fixed-price delivery order with no set-aside designation, indicating competitive award. Performance will occur at the vendor's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract executed under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), which carries a ceiling value of $999,999,999 and extends through December 2026.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal medical procurement vendor, fulfills this order as part of its comprehensive role supplying pharmaceuticals and medical devices to the Defense Health Agency and military healthcare systems. The company's extensive federal contract portfolio demonstrates consistent capability to meet competitive procurement requirements across multiple therapeutic domains, including specialty medications, vaccines, and medical supplies. This particular delivery order for Xyosted—a testosterone replacement therapy auto-injector—supports the company's ongoing provision of specialized pharmaceutical products to military and federal healthcare operations through the DLA's global pharmaceutical supply network.
Quick answers
Who was awarded contract SPE2DB25FY9LG?
SPE2DB25FY9LG was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on August 15, 2025.
How much is contract SPE2DB25FY9LG worth?
The government has obligated $1,086 on SPE2DB25FY9LG.
Is contract SPE2DB25FY9LG an order under another contract?
Yes. SPE2DB25FY9LG is a delivery order under SPE2DB22D3301, an indefinite delivery contract.
Was contract SPE2DB25FY9LG competed?
The extent of competition for SPE2DB25FY9LG was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award